A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokers
- 3 November 2010
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 399 (2) , 877-889
Abstract
Polycyclic aromatic hydrocarbons (PAH) are products of the incomplete combustion of organic materials and, therefore, occur ubiquitously in the environment and also in tobacco smoke. Since some PAH have been classified as carcinogens, it is important to have access to suitable analytical methods for biomarkers of exposure to this class of compounds. Past experience has shown that measuring a profile of PAH metabolites is more informative than metabolites of a single PAH. Assessment of environmental and smoking-related exposure levels requires analytical methods with high sensitivity and specificity. In addition, these methods should be fast enough to allow high throughput. With these pre-conditions in mind, we developed and validated a high-performance liquid chromatographic method with tandem mass spectrometric detection (LC-MS/MS) for the determination of phenolic metabolites of naphthalene, fluorene, phenanthrene and pyrene in urine of smokers and non-smokers. Sample work-up comprised enzymatic hydrolysis of urinary conjugates and solid-phase extraction on C18 cartridges. The method showed good specificity, sensitivity, and accuracy for the intended purpose and was also sufficiently rapid with a sample throughput of about 350 per week. Application to urine samples of 100 smokers and 50 non-smokers showed significant differences between both groups for all measured PAH metabolites, and strong correlations with markers of daily smoke exposure in smoker urine. Urinary levels were in good agreement with previously reported data using different methodologies. In conclusion, the developed LC-MS/MS method is suitable for the quantification of phenolic PAH metabolites of naphthalene, fluorene, phenanthrene, and pyrene in smoker and non-smoker urine. Figure Cumulative frequencies of urinary 4-OH-Phe (left, not significantly influenced by smoking) and 1-OH-Pyr (right, significantly elevated in smokers)Keywords
This publication has 44 references indexed in Scilit:
- Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro SnusNicotine & Tobacco Research, 2009
- Using liquid chromatography–tandem mass spectrometry to quantify monohydroxylated metabolites of polycyclic aromatic hydrocarbons in urineJournal of Chromatography B, 2009
- Involuntary Tobacco Smoke Exposure and Urinary Levels of Polycyclic Aromatic Hydrocarbons in the United States, 1999 to 2002Cancer Epidemiology, Biomarkers & Prevention, 2009
- Urinary polycyclic aromatic hydrocarbons and monohydroxy metabolites as biomarkers of exposure in coke oven workersOccupational and Environmental Medicine, 2009
- Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposalTobacco Control, 2008
- Urinary 1‐hydroxypyrene concentrations in Chinese coke oven workers relative to job category, respirator usage, and cigarette smokingAmerican Journal of Industrial Medicine, 2007
- Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolitesEnvironmental Research, 2006
- Carcinogen Exposure during Short-term Switching from Regular to “Light” CigarettesCancer Epidemiology, Biomarkers & Prevention, 2005
- Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbonsAnnals of Occupational Hygiene, 2001
- Benzo-a-Pyrene: Environmental Partitioning and Human ExposureToxicology and Industrial Health, 1991